In an 85‑year‑old patient who is bradycardic and hypertensive, cannot swallow whole tablets, and cannot take amlodipine (Norvasc) due to peripheral edema, and is currently on losartan 100 mg daily, hydrochlorothiazide 12.5 mg daily, and hydralazine 100 mg three times daily, what medication can be added next?

Add Spironolactone as the Fourth Agent

For this 85-year-old bradycardic, hypertensive patient already on losartan 100mg, HCTZ 12.5mg, and hydralazine 100mg TID, the next medication to add is spironolactone 25mg daily, starting at a low dose given her age and monitoring closely for hyperkalemia and renal function.

Rationale for Spironolactone

This patient has resistant hypertension (uncontrolled BP on three agents including a diuretic) and requires a fourth-line agent. The 2017 ACC/AHA guidelines 1 and 2024 ESC guidelines 2 both identify spironolactone as the preferred add-on therapy in resistant hypertension, with Class I evidence demonstrating superior BP reduction compared to other fourth-line options.

The 2025 ACC/AHA guidelines 3 specifically note that spironolactone 25-50mg/day reduced home and 24-hour systolic BP by 6.6 to 8.7 mmHg compared to placebo in resistant hypertension patients, with greater efficacy than doxazosin or bisoprolol.

Why This Patient's Constraints Support Spironolactone

Bradycardia Eliminates Beta-Blockers

Beta-blockers are contraindicated given her existing bradycardia 1, 4, 5. This removes a common fourth-line option.

Cannot Crush Medications

Spironolactone tablets can be crushed if needed (though the standard 25mg tablet is small and often manageable). More importantly, it's dosed once daily, improving adherence 1.

Amlodipine Intolerance Due to Edema

Her documented peripheral edema from amlodipine eliminates dihydropyridine calcium channel blockers 6. Research confirms that amlodipine causes dose-dependent peripheral edema in up to 31% of patients at 10mg 7, 8. Hydralazine itself can worsen edema through sodium and water retention 1, 9, making spironolactone's aldosterone antagonism particularly beneficial here.

Already on Maximum ARB Dose

She's on losartan 100mg (maximum dose), so further titration isn't possible 5.

Dosing and Monitoring Protocol

Starting dose: 12.5-25mg daily (lower end given age 85) 1, 10

Before initiating:

• Check serum potassium (must be <5.0 mEq/L)
• Check eGFR (should be ≥45 mL/min/1.73m²) 3
• Ensure she's not on other potassium-sparing agents

Monitoring schedule:

• Recheck potassium and creatinine at 1 week, then 1 month, then every 3 months 1
• Watch for hyperkalemia (4-40% incidence) 3
• Monitor for antiandrogenic effects (less common in women but can occur)

Titration: Can increase to 50mg daily after 4-6 weeks if BP remains uncontrolled and no adverse effects 1, 10

Alternative Fourth-Line Options (If Spironolactone Fails or Is Contraindicated)

If spironolactone causes hyperkalemia or is otherwise not tolerated:

1. Eplerenone 50mg daily (more selective, fewer antiandrogenic effects but still risk of hyperkalemia) 1, 2
2. Amiloride 5-10mg daily (potassium-sparing without hormonal effects) 11, 2
3. Doxazosin 1-4mg daily (alpha-blocker, but significant orthostatic hypotension risk in elderly) 1, 11
4. Clonidine 0.1mg twice daily (central alpha-agonist, but CNS side effects problematic in elderly) 1, 4

Critical Caveats

Do NOT combine spironolactone with:

• Additional potassium supplements
• Other potassium-sparing diuretics
• NSAIDs (increases hyperkalemia risk)

The hydralazine dose is already high (300mg/day total), which may be contributing to reflex tachycardia and fluid retention 1, 9. Consider whether this could be reduced once spironolactone is added and BP improves.

Age-related considerations: At 85, she may have reduced renal function even with normal creatinine due to decreased muscle mass. Calculate actual eGFR before starting 3.

1, 10, 4, 5, 11, 3, 2